Anabella Villalobos
Board Member
Coya Therapeutics, Inc. (COYA)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Anabella Villalobos
Anabella Villalobos is recorded as Board Member at Coya Therapeutics, Inc. (COYA). Coya Therapeutics, Inc. reported in an 8-K filed May 8, 2024 that Anabella Villalobos was appointed Class II director, effective May 8, 2024.
“The election of Anabella Villalobos, Ph.D. and Dov Goldstein, M.D., M.B.A., as Class II directors to hold office for a term of three years, until their successors are duly elected and qualified or they are otherwise unable to complete their respective terms.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2021-01-01–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Coya Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Arun Swaminathan CEO, Board Member
- Dr. Arun Swaminathan CEO
- Howard Berman Chairman
- David Snyder CFO, Board Member
- Anabella Villalobos, Ph.D. Board Member
- Ann Lee Board Member
- Dieter Weinand Board Member
- Dov Goldstein Board Member
- Dov Goldstein, M.D., M.B.A. Board Member
- Fred Grossman Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.